Skip to content

Factors Affecting Selection of Leadless Pacemaker and Atrioventricular Synchronous Pacing Status

Factors Affecting Selection of Leadless Pacemaker in Patients with Atrioventricular Block and Atrioventricular Synchronous Pacing Status with a Micra AV: a Multicenter, Prospective, Observational Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06587672
Enrollment
112
Registered
2024-09-19
Start date
2024-09-15
Completion date
2027-07-31
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrioventricular Block, Clinical Trials, Pacemaker, Pacing

Keywords

Leadless pacing, Atrioventricular synchrony, Atrioventricular block, Atrial contraction

Brief summary

This is a multicenter, prospective, observational study ,the aim of this study is to find factors affecting selection of double-chamber leadless pacemaker in patients with atrioventricular block and ambulatory atrioventricular synchronous pacing status over time using a leadless ventricular pacemaker.

Detailed description

Traditional pacemakers consist of a pulse generator and leads. Infections of the pulse generator pocket and lead-related complications are unavoidable issues in the application oftraditional pacemakers.Leadless pacemakers have emerged to address complications associated with the pacemaker pocket and leads in specific patients.The initial design of leadless pacemakers focused on single-chamber (right ventricular)sensing and pacing,However, patients with sinus rhythm may experience pacemakersyndrome symptoms due to atrioventricular desynchrony. Furthermore, a high proportion of atrioventricular dyssynchronous ventricular pacing might increase hospitalization rates for atrial fibrillation and heart failure.Recent developments in leadless dual-chamber pacemakersutilize a built-in triaxial accelerometer.This study aims to investigate factors considered by patients with atrioventricular block and clinical pacemaker implanting physicians when make sure the use of Micra AV. 2). It also seeks to evaluate the atrioventricular synchrony of Micra AV pacing in patients during both exercise and rest, while analyzing factors that influence the AV synchrony.For all screened patients, a questionnaire is required to be finished with data including age, gender, occupation, educational level, clinical history, comorbidities, previous infections, history of implanted electronic devices, economic status, and medical insurance conditions. At same time, all physicians are asked to complete a questionnaire for analyzing the factors influencing the decision of device option.An ambulatory electrocardiogram will be performed at 3 months, 6 months, and 1 year follow-up after device implantation. Data regarding the proportion of atrioventricular Research Protocol Template (Observational Study)\_V1.0\_2023.10.04 7/10 synchrony, atrial sensing atrial contraction mechanical wave (A4) threshold, ventricular pacing threshold, sensing, and impedance will be tested and collected. Postoperative exercise related symptoms and adverse events will be routinely tracked.

Interventions

DEVICEMicra AV implantation

Patients received Micra AV implantation

Sponsors

Tianjin Chest Hospital
CollaboratorOTHER
Beijing Friendship Hospital
CollaboratorOTHER
Beijing Hospital
CollaboratorOTHER_GOV
Peking University First Hospital
CollaboratorOTHER
Xiaohan Fan
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients diagnosed with atrioventricular conduction block, meeting the indications for dual-chamber leadless pacemakers as per the Chinese Expert Consensus on Clinical Application of Leadless Pacemakers (2022). 2. Age ≥18 years. 3. Expected lifespan ≥1 year. 4. Consent to sign an informed consent form and cooperate in the collection of baseline data and subsequent follow-ups

Exclusion criteria

1. Patients anticipated to have a high ventricular pacing proportion (\>40%) and with left ventricular ejection fraction less than 50%. 2. Patients with persistent atrial fibrillation and a high expected ventricular pacing proportion. 3. Post-tricuspid valve mechanical valve replacement surgery. 4. Patients with inferior vena cava pathway anomalies, precluding passage of the leadless pacemaker's delivery sheath. 5. Patients with an expected lifespan of less than 1 year. 6 Patients who are pregnant, planning pregnancy, or undergoing cardiac transplantation.

Design outcomes

Primary

MeasureTime frameDescription
Complete the survey questionnair before implanting a pacemaker1 day before implanting a pacemakerComplete the survey questionnair
The percentage of atrioventricular synchrony at 3 months after Micra AV implantation.3 months post-implantThe percentage of atrioventricular synchrony will be calculated based on the recording of a 20-minute resting period in the outpatient consulting room, via dividing the total number of AV synchronous cycles by the total number of cardiac cycles recoded by a Holter. An AV synchronous cycle will be defined as a paced or sensed ventricular beat within 300 ms following a surface ECG confirmed P-wave.

Secondary

MeasureTime frameDescription
Ventricular pacing threshold, at 3 months, 6 months, and 1 year after Micra AV implantation.3, 6, 12months post-implantMeasuring the ventricular pacing threshold by a programmer at the outpatient clinic at 3,6 and 12 month.
Ventricular sensing at 3 months, 6 months, and 1 year after Micra AV implantation.3, 6, 12 months post-implantMeasuring ventricular sensing by a programmer at the outpatient clinic at 3,6 and 12 month.
Impedance at 3 months, 6months, and 1 year after Micra AV implantation.3, 6, 12 months post-implantMeasuring Impedance by a programmer at the outpatient clinic at 3,6 and 12 month.
Major complications related to the device implantation at perioperative period, and 3, 6, 9, 12 months after Micra AV implantationDays 0,1 and 3, 6, 9, 12 months post- implantMajor complations related to the device implantation include, pericardial effusion, dislodgement, threshold elevation or loss of capture, infection, etc.
All-cause mortality rates at 3 months, 6 months, and 1 year after Micra AV implantation.3, 6, 9, 12 months post-implantThese data will be collected at the outpatient clinic at 3,6 and 12 month, 9-month follow-up will be conducted via telephone.
Rehospitalization events related to heart failure at 3 months, 6 months, and 1year after Micra AV implantation.3, 6, 12 months post-implantRehospitalization events due to heart failure at 3 months, 6 months, and 1year after Micra AV implantation.
Immediate success rate of Micra AV implantation.During implantation on day 0Successfully implant a Micra AV during procedure.
Left venriculat ejection fraction measured by echocardiography at 6, 12 months after Micra AV implanted6, 12 months post-implantLeft venriculat ejection fraction measured by echocardiography.
Left ventricular end-diastolic diameter measured by echocardiography at 6, 12 months after Micra AV implantation.6, 12 months post-implantLeft ventricular end-diastolic diameter measured by echocardiography
Parameter adjustment events related to the synchrony less than 70% at 3, 6, 12 months after Micra AV implantation..3, 6, 12months post-implantParameter adjustment event will be defined as optimamizing the pacemaker parameters due to synchrony less than 70%.
Arrhythmias events at 3, 6, 12 months after Micra AV implantion3, 6, 12months post-implantAll kinds of arrhythmias events recorded via electrocardiogram or device during the follow up
Syncope events at 3, 6, 12 months after Micra AV implantion3, 6, 12months post-implantSyncope events during the follow up
Tachycardia related to the pacemaker, or adverse events related to the device or algorithm at 3, 6, 12 months after Micra AV implantation.3,6,12 months post-implantTachycardia or or adverse events related to the device or algorithm during the follow-up
The percentage of atrioventricular synchrony at 6, 12 months after Micra AV implantation.6, 12 months post-implantThe percentage of atrioventricular synchrony will be calculated based on the recording of a 20-minute resting period in the outpatient consulting room, via dividing the total number of AV synchronous cycles by the total number of cardiac cycles recoded by a Holter. An AV synchronous cycle will be defined as a paced or sensed ventricular beat within 300 ms following a surface ECG confirmed P-wave.

Countries

China

Contacts

Primary ContactXiaohan Fan
fanxiaohan@fuwaihospital.org+861088322393

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026